These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38467792)

  • 1. Copper's dual role: unravelling the link between copper homeostasis, cuproptosis, and cardiovascular diseases.
    Parsanathan R
    Hypertens Res; 2024 May; 47(5):1440-1442. PubMed ID: 38467792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease.
    Wang D; Tian Z; Zhang P; Zhen L; Meng Q; Sun B; Xu X; Jia T; Li S
    Biomed Pharmacother; 2023 Jul; 163():114830. PubMed ID: 37150036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper homeostasis and cuproptosis in gynecological disorders: Pathogenic insights and therapeutic implications.
    Lin Y; Yuan M; Wang G
    J Trace Elem Med Biol; 2024 Jul; 84():127436. PubMed ID: 38547725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATF3/SPI1/SLC31A1 Signaling Promotes Cuproptosis Induced by Advanced Glycosylation End Products in Diabetic Myocardial Injury.
    Huo S; Wang Q; Shi W; Peng L; Jiang Y; Zhu M; Guo J; Peng D; Wang M; Men L; Huang B; Lv J; Lin L
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cope with copper: From molecular mechanisms of cuproptosis to copper-related kidney diseases.
    Zou Y; Wu S; Xu X; Tan X; Yang S; Chen T; Zhang J; Li S; Li W; Wang F
    Int Immunopharmacol; 2024 May; 133():112075. PubMed ID: 38663316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cuproptosis: Unraveling the Mechanisms of Copper-Induced Cell Death and Its Implication in Cancer Therapy.
    Springer C; Humayun D; Skouta R
    Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cuproptosis and physical training: A review.
    Kordi N; Saydi A; Azimi M; Mazdarani F; Gadruni K; Jung F; Karami S
    Clin Hemorheol Microcirc; 2024 Jul; ():. PubMed ID: 39031346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategies.
    Chen X; Cai Q; Liang R; Zhang D; Liu X; Zhang M; Xiong Y; Xu M; Liu Q; Li P; Yu P; Shi A
    Cell Death Dis; 2023 Feb; 14(2):105. PubMed ID: 36774340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper Homeostasis Based on Cuproptosis-Related Signature Optimizes Molecular Subtyping and Treatment of Glioma.
    Zhang S; Yu H; Sun S; Fan X; Bi W; Li S; Wang W; Fang Z; Chen X
    Mol Neurobiol; 2024 Aug; 61(8):4962-4975. PubMed ID: 38151613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cuproptosis, the novel type of oxidation-induced cell death in thoracic cancers: can it enhance the success of immunotherapy?
    Zhao R; Sukocheva O; Tse E; Neganova M; Aleksandrova Y; Zheng Y; Gu H; Zhao D; Madhunapantula SV; Zhu X; Liu J; Fan R
    Cell Commun Signal; 2024 Jul; 22(1):379. PubMed ID: 39068453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring cuproptosis as a mechanism and potential intervention target in cardiovascular diseases.
    Yang Y; Feng Q; Luan Y; Liu H; Jiao Y; Hao H; Yu B; Luan Y; Ren K
    Front Pharmacol; 2023; 14():1229297. PubMed ID: 37637426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer.
    Wang W; Lu K; Jiang X; Wei Q; Zhu L; Wang X; Jin H; Feng L
    J Exp Clin Cancer Res; 2023 Jun; 42(1):142. PubMed ID: 37277863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper homeostasis and cuproptosis in cardiovascular disease therapeutics.
    Yang L; Yang P; Lip GYH; Ren J
    Trends Pharmacol Sci; 2023 Sep; 44(9):573-585. PubMed ID: 37500296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper Metabolism and Cuproptosis: Molecular Mechanisms and Therapeutic Perspectives in Neurodegenerative Diseases.
    Ban XX; Wan H; Wan XX; Tan YT; Hu XM; Ban HX; Chen XY; Huang K; Zhang Q; Xiong K
    Curr Med Sci; 2024 Feb; 44(1):28-50. PubMed ID: 38336987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles and mechanisms of copper homeostasis and cuproptosis in osteoarticular diseases.
    Han J; Luo J; Wang C; Kapilevich L; Zhang XA
    Biomed Pharmacother; 2024 May; 174():116570. PubMed ID: 38599063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine enables copper homeostasis in cerebral ischemia/reperfusion via ferredoxin 1.
    Guo Q; Ma M; Yu H; Han Y; Zhang D
    Ann Med; 2023 Dec; 55(1):2209735. PubMed ID: 37162502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer.
    Yang W; Wang Y; Huang Y; Yu J; Wang T; Li C; Yang L; Zhang P; Shi L; Yin Y; Tao K; Li R
    Biomed Pharmacother; 2023 Mar; 159():114301. PubMed ID: 36706634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cuproptosis, the novel therapeutic mechanism for heart failure: a narrative review.
    Yuan HJ; Xue YT; Liu Y
    Cardiovasc Diagn Ther; 2022 Oct; 12(5):681-692. PubMed ID: 36329965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance.
    Wang Y; Chen Y; Zhang J; Yang Y; Fleishman JS; Wang Y; Wang J; Chen J; Li Y; Wang H
    Drug Resist Updat; 2024 Jan; 72():101018. PubMed ID: 37979442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cuproptosis: unveiling a new frontier in cancer biology and therapeutics.
    Feng Y; Yang Z; Wang J; Zhao H
    Cell Commun Signal; 2024 May; 22(1):249. PubMed ID: 38693584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.